A xenograft animal model of human arteriovenous malformations.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3879430)

Published in Orphanet J Rare Dis on December 30, 2013

Authors

Fang Hou, Yuemeng Dai, James Y Suen, Chunyang Fan, Ali G Saad, Gresham T Richter1

Author Affiliations

1: Center for the Investigation of Congenital Aberrancies of Vascular Development, Little Rock, AR, USA. gtrichter@uams.edu.

Articles cited by this

The Ki-67 protein: from the known and the unknown. J Cell Physiol (2000) 16.48

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature (1997) 7.10

Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg (1998) 3.42

Vascular anomalies. Curr Probl Surg (2000) 2.60

Sperm from neonatal mammalian testes grafted in mice. Nature (2002) 2.34

Current management of hemangiomas and vascular malformations. Clin Plast Surg (2005) 2.27

VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front Biosci (2006) 1.65

Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg (2004) 1.52

Animal model for cerebral arteriovenous malformation. Acta Neurochir (Wien) (2000) 1.51

Endothelial progenitor cells in infantile hemangioma. Blood (2003) 1.50

Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke (2003) 1.25

Matrix Gla protein deficiency causes arteriovenous malformations in mice. J Clin Invest (2011) 1.23

Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg (2001) 1.22

Surgical treatment for congenital arteriovenous malformation: 10 years' experience. Eur J Vasc Endovasc Surg (2006) 1.20

Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery (2001) 1.18

Multidisciplinary approach to the management of head and neck arteriovenous malformations. Ann R Coll Surg Engl (1995) 1.10

EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol (1998) 1.08

Interstitial Nd:YAG photocoagulation for vascular malformations and hemangiomas in childhood. Arch Otolaryngol Head Neck Surg (1998) 1.08

Microvascular proliferation in congenital vascular malformations of skin and soft tissue. J Clin Pathol (2006) 1.05

Congenital arteriovenous malformations of the face and scalp. J Cardiovasc Surg (Torino) (1968) 0.99

Management of vascular malformations of the mandible and maxilla. Laryngoscope (2003) 0.96

Evidence of endothelial progenitor cells in the human brain and spinal cord arteriovenous malformations. Neurosurgery (2010) 0.95

A novel in vivo model of human hemangioma: xenograft of human hemangioma tissue on nude mice. Plast Reconstr Surg (2007) 0.93

Arteriovenous malformations of the tongue: a spectrum of disease. Laryngoscope (2007) 0.91

Reconstructed human skin produced in vitro and grafted on athymic mice. Transplantation (2002) 0.91

Long-term survival of normal adult human tissues as xenografts in congenitally athymic nude mice. J Natl Cancer Inst (1981) 0.89

Long-term remodeling of a bilayered living human skin equivalent (Apligraf) grafted onto nude mice: immunolocalization of human cells and characterization of extracellular matrix. Wound Repair Regen (2003) 0.88

Angiographic, hemodynamic and histological characterization of an arteriovenous fistula in rats. Acta Neurochir (Wien) (2004) 0.86

Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery (2002) 0.85

Clinical course of arteriovenous malformations of the head and neck: a case series. Otolaryngol Head Neck Surg (2010) 0.83

The effects of a carotid-jugular fistula on cerebral blood flow in the cat: an experimental study in the chronic period. Neurol Res (1995) 0.78

The establishment of the hemangioma model in nude mouse. J Pediatr Surg (2005) 0.78

Expression of endoglin (CD105) and endothelial nitric oxide synthase in head and neck arteriovenous malformations. JAMA Otolaryngol Head Neck Surg (2013) 0.77

[Arteriovenous malformations: a study of 200 cases]. Ann Dermatol Venereol (2000) 0.77

Treatment for extracranial arteriovenous malformations of the head and neck. Acta Otolaryngol (2006) 0.77

A pilot in vivo model of human microcystic lymphatic malformations. Arch Otolaryngol Head Neck Surg (2011) 0.76

Graves' disease: xenotransplantation model (athymic nude mice). J Mol Med (Berl) (1999) 0.76

Articles by these authors

Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13

In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser. Cancer Res (2009) 2.48

Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J Cell Biochem (2005) 1.64

Clinical study for alleviating opiate drug psychological dependence by a method of ablating the nucleus accumbens with stereotactic surgery. Stereotact Funct Neurosurg (2003) 1.59

Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood (2007) 1.49

Treatment guideline for hemangiomas and vascular malformations of the head and neck. Head Neck (2010) 1.40

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35

Salivary duct carcinoma. Otolaryngol Head Neck Surg (2003) 1.28

Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope (2010) 1.21

Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo. J Biol Chem (2009) 1.18

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med (2002) 1.06

Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg (2004) 1.04

Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (2007) 1.02

Real-time monitoring of circulating tumor cell release during tumor manipulation using in vivo photoacoustic and fluorescent flow cytometry. Head Neck (2013) 1.02

Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev (2004) 1.00

Guidelines for the treatment of head and neck venous malformations. Int J Clin Exp Med (2013) 0.99

O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2004) 0.97

Diagnosis and management of pediatric cervicofacial venous malformations: retrospective review from a vascular anomalies center. Laryngoscope (2010) 0.97

Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer. Head Neck (2012) 0.93

Bisphosphonates and jaw osteonecrosis: the UAMS experience. Otolaryngol Head Neck Surg (2007) 0.93

Human recombinant vascular endothelial growth factor reduces necrosis and enhances hepatocyte regeneration in a mouse model of acetaminophen toxicity. J Pharmacol Exp Ther (2010) 0.92

Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol (2003) 0.90

Progesterone receptors identified in vascular malformations of the head and neck. Otolaryngol Head Neck Surg (2009) 0.90

Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients. J Exp Clin Cancer Res (2011) 0.89

Considerations in incorporating office-based ultrasound of the head and neck. Otolaryngol Head Neck Surg (2006) 0.89

The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol (2003) 0.88

The eye limits the brain's learning potential. Sci Rep (2012) 0.87

Radiation-associated meningiomas in children: clinical, pathological, and cytogenetic characteristics with a critical review of the literature. J Neurosurg Pediatr (2012) 0.86

The expression of vascular endothelial growth factor and its receptors in port-wine stains. Otolaryngol Head Neck Surg (2008) 0.85

Using 10AFC to further improve the efficiency of the quick CSF method. J Vis (2015) 0.83

Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Epigenetics (2015) 0.83

Clinical course of arteriovenous malformations of the head and neck: a case series. Otolaryngol Head Neck Surg (2010) 0.83

Endoscopic management of airway venous malformations with Nd:YAG laser. Ann Otol Rhinol Laryngol (2010) 0.82

Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg (2002) 0.81

Neurosurgical Site Infection Prevention: Single Institute Experience. Turk Neurosurg (2016) 0.80

Prolonged stability of progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia. J Clin Oncol (2010) 0.80

Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer. Mol Med Rep (2013) 0.79

Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol (2003) 0.79

Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg (2009) 0.79

Loss of cytokeratin 20 and acquisition of thyroid transcription factor-1 expression in a merkel cell carcinoma metastasis to the brain. Am J Dermatopathol (2014) 0.79

Recurrent meningitis associated with frontal sinus tuber encephalocele in a patient with tuberous sclerosis. J Neurosurg Pediatr (2011) 0.79

Evaluating the performance of the quick CSF method in detecting contrast sensitivity function changes. J Vis (2016) 0.78

Evaluation of the inferior and superior laryngeal nerve stumps for perineural spread in laryngeal cancer. Otolaryngol Head Neck Surg (2007) 0.78

Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia. Arch Otolaryngol Head Neck Surg (2011) 0.78

A hierarchical Bayesian approach to adaptive vision testing: A case study with the contrast sensitivity function. J Vis (2016) 0.78

SNVerGUI: a desktop tool for variant analysis of next-generation sequencing data. J Med Genet (2012) 0.78

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer. Pharmgenomics Pers Med (2013) 0.77

Primary diffuse cerebral leptomeningeal atypical teratoid rhabdoid tumor: report of the first case. J Neurooncol (2009) 0.77

Expression of endoglin (CD105) and endothelial nitric oxide synthase in head and neck arteriovenous malformations. JAMA Otolaryngol Head Neck Surg (2013) 0.77

[Impact of misuse of antimicrobial therapies on inpatient costs]. Beijing Da Xue Xue Bao (2010) 0.77

Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma. Laryngoscope (2009) 0.77

Pediatric extracranial arteriovenous malformations. Curr Opin Otolaryngol Head Neck Surg (2011) 0.77

Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas. Arch Otolaryngol Head Neck Surg (2012) 0.77

Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma. Brain Tumor Pathol (2011) 0.76

Lysyl oxidase genetic variants affect gene expression in cervical cancer. DNA Cell Biol (2014) 0.76

A pilot in vivo model of human microcystic lymphatic malformations. Arch Otolaryngol Head Neck Surg (2011) 0.76

Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells. Otolaryngol Head Neck Surg (2011) 0.75

Use of recombinant factor VIIa during excision of vascular anomalies. Laryngoscope (2007) 0.75

Herpes simplex infection of the larynx requiring laryngectomy. Am J Otolaryngol (2013) 0.75

Free tissue reconstruction following excision of head and neck arteriovenous malformations. Arch Facial Plast Surg (2009) 0.75

Pharmacokinetics of intravenous teicoplanin in peritoneal dialysis patients with respiratory infections. Perit Dial Int (2011) 0.75

Submucosal nerve hypertrophy in congenital laryngomalacia. Laryngoscope (2011) 0.75

The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population. Liver Int (2009) 0.75

Nigrostriatal projecting neurons express GDNF receptor subunit RET in adult rats. Acta Neurobiol Exp (Wars) (2008) 0.75

First bite syndrome: case report of 3 patients treated with botulinum toxin and review of other treatment modalities. Head Neck (2012) 0.75

Large Tumefactive IgG4-related Disease: Histologic, Cytologic, and Immunohistochemical Features of a Very Unusual Case. Appl Immunohistochem Mol Morphol (2017) 0.75

Giant frontal colliding meningiomas in a child: histopathologic, cytogenetic, and ultrastructural descriptions of a unique case. Pediatr Dev Pathol (2011) 0.75

Refractory seizures due to a dural-based cavernoma masquerading as a meningioma. Neurol Sci (2011) 0.75

Preliminary investigation of human lymphatic malformations in vitro. Laryngoscope (2011) 0.75

47-year-old man with left leg numbness. Brain Pathol (2013) 0.75